METHOD OF SELECTING PATIENTS FOR TREATMENT WITH AN IL-33 AXIS ANTAGONIST

Methods for Categorizing and Treating Subjects at Risk for Pulmonary Exacerbation and Disease Progression

USE OF STROMAL CELL-DERIVED FACTOR 1 (SDF1) AS A BIOMARKER FOR DIAGNOSING AND TREATING SEVERE ACUTE RESPIRATORY DISTRESS SYNDROME (ARDS)

DEVICES AND METHODS FOR TREATING ISCHAEMIA AND ACUTE RESPIRATORY DISTRESS SYNDROMES

COMPOSITIONS AND METHODS FOR TREATING PULMONARY EDEMA OR LUNG INFLAMMATION

BIOMARKERS FOR DETECTING OF OUTCOME/RISK OF THE PATIENTS WITH A RESPIRATORY ILLNESS

Methods for categorizing and treating subjects having cystic fibrosis (CF) and at risk for severe pulmonary exacerbation

Method for assisting prediction of exacerbation of respiratory infection, and device to assist in predicting exacerbation of respiratory infection

Methods for Categorizing and Treating Subjects at Risk for Pulmonary Exacerbation and Disease Progression

Complex-specific standardization of immunological methods for the quantification of S100A12

Methods for categorizing and treating subjects at risk for pulmonary exacerbation and disease progression

Predictive biomarkers of clinical response to anti-LPS immunoglobulin treatment

Telocinobufagin (TCINO) in the Diagnosis and Pathogenesis of Preeclampsia, Traumatic Brain Injury and Acute Respiratory Distress Syndrome

Methods and system for use in neonatal diagnostics

DETECTING COMPLEMENT ACTIVATION

Method for determining acute respiratory distress syndrome (ARDS) related biomarkers, a method to monitor the development and treatment of ARDS in a patient

Lateral flow immunoassay for complement activation and methods of use for point-of-care assessment of complement-associated disorders

Method for treating pulmonary exacerbation and disease progression in subjects having cystic fibrosis

MARKER PEPTIDES FOR DETERMINING THE OCCURRENCE OF AN INFLAMMATORY STATE IN A SUBJECT

Therapeutic agent, treatment method and inspection method for diseases caused by activation of neutrophils

Detecting complement activation

HMG1 antibody for treating inflammatory conditions

Detecting complement activation

Monoclonal antibody against human HIG-1 polypeptide

Lateral flow immunoassay for complement activation and methods of use for point-of-care assessment of complement-associated disorders

MARKER PEPTIDES FOR DETERMINING THE OCCURRENCE OF AN INFLAMMATORY STATE IN A SUBJECT

Compositions and methods for treating lung disorders

Compositions and uses thereof for the treatment of acute respiratory distress syndrome (ARDS) and clinical disorders associated with therewith

HMG1 antibody for treating inflammatory conditions

Antagonists of HMG1 for treating inflammatory conditions

Methods of Employing Vascular Leakage to Diagnose a Capillary Leak Disorder

Pigment epithelium-derived factor as a therapeutic agent for vascular leakage

Antagonists of HMG1 for treating inflammatory conditions

Methods of diagnosing sepsis by measuring HMG1

Hypoxia inducible factor 2α for curing neonatal respiratory distress syndrome and as a target for the treatment of pulmonary hypertension

Use of hypoxia inducible factor 2alpha for curing neonatal respiratory distress syndrome and as a target for the treatment of pulmonary hypertension